During the past decade, Palo Alto Medical Foundation conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 20 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 10 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Palo Alto Medical Foundation" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 12 trials, followed by "NSABP Foundation Inc" with 2 trials sponsored, "Palo Alto Medical Foundation" with 2 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "Alliance Foundation Trials, LLC." with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Palo Alto Medical Foundation" #1 collaborator was "National Cancer Institute (NCI)" with 18 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator, "Stanford University" with 2 trials as a collaborator and "University of Illinois at Chicago" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Palo Alto Medical Foundation" are "Breast Cancer" (7 trials), "Prostate Cancer" (3 trials), "Colorectal Cancer" (2 trials), "Lung Cancer" (2 trials) and "Obesity" (2 trials). Many other conditions were trialed in "Palo Alto Medical Foundation" in a lesser frequency.

Most popular intervention types in "Palo Alto Medical Foundation" are "Drug" (19 trials), "Other" (6 trials), "Biological" (4 trials), "Device" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (5 trials), "axillary lymph node dissection" (2 trials), "carboplatin" (2 trials), "prednisone" (2 trials) and "radiation therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Palo Alto Medical Foundation" are 21 trials for "All" genders, 6 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Palo Alto Medical Foundation". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Palo Alto Medical Foundation, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Palo Alto Medical Foundation, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".